# A Post-Market Clinical Performance and Safety Evaluation of GamCath HighFlow Dolphin Protect Catheter

> **NCT05888376** · — · COMPLETED · sponsor: **Vantive Health LLC** · enrollment: 76 (actual)

## Conditions studied

- AKI - Acute Kidney Injury
- Acute Renal Failure
- CKD
- ESRD

## Interventions

- **DEVICE:** Vascular access catheter to support dialysis or CRRT

## Key facts

- **NCT ID:** NCT05888376
- **Lead sponsor:** Vantive Health LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-07
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-04-30
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2025-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05888376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05888376, "A Post-Market Clinical Performance and Safety Evaluation of GamCath HighFlow Dolphin Protect Catheter". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT05888376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*